Sevigny Jeffrey

Sevigny Jeffrey is listed in filings as Chief Medical Officer at Rapport Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Feb 4, 2026, including 2 public disclosures. Recent filings connect the profile to Rapport Therapeutics, Inc. Common Stock (RAPP). The current snapshot covers public activity from Apr 3, 2025 to Feb 4, 2026. Reported amounts are shown as $3.6M to $2.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.